Also available in Persian — نسخه فارسی EN فا
❓ Unknown

The United States Prevents Adoption of a Treaty Draft at the World Trade Organization

Feb 11, 2026 February 11, 2026 1 min read 📰 VOA Persian
📋 Key Takeaway

The United States has blocked a treaty at the World Trade Organization that would allow developing countries to produce affordable copies of essential medicines. This decision has drawn criticism, as it is seen as influenced by pharmaceutical companies. The matter is significant as it affects access to healthcare in poorer nations.

🔍 Quick Context Guide
💡 Bottom Line: The U.S. decision to block the treaty could hinder access to affordable medicines for developing countries, raising concerns about global health equity.

👥 Key Players

United States MENTIONED
Member of the World Trade Organization
"As a major global economy, the U.S. has significant influence over international trade policies and agreements, impacting access to medicines worldwide."
World Trade Organization (WTO) MENTIONED
International organization that regulates trade between nations
"The WTO facilitates trade agreements and negotiations, which can affect global health policies and access to essential medicines."
Pharmaceutical Companies MENTIONED
Industry stakeholders
"These companies are directly impacted by patent laws and have a vested interest in maintaining strong protections for their products."

📰 What Happened

The United States blocked a treaty draft at the World Trade Organization that aimed to allow developing countries to produce affordable copies of essential medicines. This decision was made despite overwhelming support from other member nations.

  • The U.S. was the only member among 144 to oppose the treaty draft.
  • The treaty was intended to simplify patent laws for medicines in poorer countries.

💡 Why It Matters

🇮🇷 For Iran: Iran, as a developing country, could face challenges in accessing affordable medicines if similar treaties are blocked, impacting public health.
🌍 Regional: Other developing countries in the region may also struggle to obtain essential medicines, affecting healthcare outcomes.
🌐 International: This decision reflects ongoing tensions between developed and developing nations regarding access to healthcare and the influence of pharmaceutical companies on policy.

📚 Background

The WTO plays a crucial role in regulating international trade, including agreements that affect access to medicines. Patent laws can significantly impact the availability of affordable healthcare in developing nations.

Global health policy Intellectual property rights
📡 Source: INTERNATIONAL
📊 Confidence: 70%
The article presents a critical view of U.S. actions, reflecting broader international concerns about healthcare access.

The United States has blocked the adoption of a treaty draft at the World Trade Organization that would allow developing countries to produce cheap copies of medicines for deadly diseases. Late on Friday in Geneva, Switzerland, the United States was the only member among one hundred and forty-four members of the World Trade Organization to oppose this proposal. This treaty would have simplified the issue of patent laws for medicines in poor countries. The World Trade Organization is currently pursuing this issue following a commitment made last year. The United States claims that this program could potentially threaten the effectiveness of patent protection laws for all medicines and insists that this treaty should be limited to medicines used for treating infectious diseases. Critics accuse the United States of being influenced by large pharmaceutical companies.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →